NAV
$26.38
AUM
$2.0M
Expense Ratio
-
Dividend Yield
1.02%
Beta
0.00
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +1.81% | +2.29% | +1.81% | +1.81% | - | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ROP.SW | Roche Holding AG Ordinary Shares new | 3.03% |
| 2 | 6857.T | Advantest Corp | 2.49% |
| 3 | CS.PA | AXA SA | 2.06% |
| 4 | ASML.AS | ASML Holding NV | 2.04% |
| 5 | ALV.DE | Allianz SE | 1.91% |
| 6 | SAF.PA | Safran SA | 1.64% |
| 7 | DANSKE.CO | Danske Bank AS | 1.60% |
| 8 | 8750.T | Daiichi Life Group Inc | 1.56% |
| 9 | RIO.AX | Rio Tinto Ltd | 1.54% |
| 10 | POW.TO | Power Corporation of Canada Shs Subord.Voting | 1.52% |
The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies in developed markets, excluding the United States. It may invest in securities of companies with any market capitalization but the adviser intends to focus on large-capitalization securities.
Inception Date: 2026-04-07